Showing 1 - 20 results of 24 for search 'Zefei Jiang', query time: 0.06s
Refine Results
-
1
Hot issues in triple-negative breast cancer by Xiaopeng Hao, Zefei Jiang
Published 2023-12-01
Article -
2
-
3
Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer by Jinmei Zhou, Xuexue Wu, Huiqiang Zhang, Xiaobo Wang, Yang Yuan, Shaohua Zhang, Zefei Jiang, Tao Wang
Published 2022-12-01
Article -
4
-
5
-
6
-
7
Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer by Yang Yuan, Shaohua Zhang, Tao Wang, Li Bian, Min Yan, Yongmei Yin, Yuhua Song, Yi Wen, Jianbin Li, Zefei Jiang, Rongman Jia, Xiuyuan Hao
Published 2023-06-01
Article -
8
A comparison between clinical decision support system and clinicians in breast cancer by Jianbin Li, Yang Yuan, Li Bian, Qiang Lin, Hua Yang, Li Ma, Ling Xin, Feng Li, Shaohua Zhang, Tao Wang, Yinhua Liu, Zefei Jiang
Published 2023-05-01
Article -
9
Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey by Jinrong Xie, Weixiang Qi, Lu Cao, Yuting Tan, Jin Huang, Xiaodong Gu, Bingguang Chen, Peipei Shen, Yutian Zhao, Ying Zhang, Qingwen Zhao, Hecheng Huang, Yubin Wang, Haicheng Fang, Zhenjun Jin, Hui Li, Xuehong Zhao, Xiaofang Qian, Feifei Xu, Dan Ou, Shubei Wang, Cheng Xu, Min Li, Zefei Jiang, Zefei Jiang, Yu Wang, Xiaobo Huang, Jiayi Chen
Published 2021-07-01
Article -
10
tRNA-Derived Fragments as Novel Predictive Biomarkers for Trastuzumab-Resistant Breast Cancer by Chunxiao Sun, Fan Yang, Yanhong Zhang, Jiahui Chu, Jian Wang, Yifan Wang, Yanqiu Zhang, Jun Li, Yongfei Li, Ruihua Fan, Wei Li, Xiang Huang, Hao Wu, Ziyi Fu, Zefei Jiang, Yongmei Yin
Published 2018-08-01
Article -
11
Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer by Fei Tian, Shaohua Zhang, Chao Liu, Ziwei Han, Yuan Liu, Jinqi Deng, Yike Li, Xia Wu, Lili Cai, Lili Qin, Qinghua Chen, Yang Yuan, Yi Liu, Yulong Cong, Baoquan Ding, Zefei Jiang, Jiashu Sun
Published 2021-05-01
Article -
12
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer by Biyun Wang, Tao Sun, Yannan Zhao, Shusen Wang, Jian Zhang, Zhonghua Wang, Yue-E Teng, Li Cai, Min Yan, Xiaojia Wang, Zefei Jiang, Yueyin Pan, Jianfeng Luo, Zhimin Shao, Jiong Wu, Xiaomao Guo, Xichun Hu
Published 2022-07-01
Article -
13
Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy by Ying Zhou, Ying Zhou, Jinmei Zhou, Jinyi Xiao, Yuehua Wang, Yuehua Wang, Hao Wang, Haoyuan Shi, Chunyan Yue, Fei Jia, Ping Li, Zhiyuan Hu, Zhiyuan Hu, Zhiyuan Hu, Zhiyuan Hu, Yanlian Yang, Yanlian Yang, Zefei Jiang, Tao Wang
Published 2022-04-01
Article -
14
An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breas... by Jinmei Zhou, Jiangling Wu, Jiangling Wu, Xiaopeng Hao, Ping Li, Huiqiang Zhang, Xuexue Wu, Jiaxin Chen, Jiawei Liu, Jinyi Xiao, Shaohua Zhang, Zefei Jiang, Yanlian Yang, Zhiyuan Hu, Zhiyuan Hu, Zhiyuan Hu, Zhiyuan Hu, Zhiyuan Hu, Tao Wang
Published 2022-08-01
Article -
15
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population by Fan Yang, Xiang Huang, Chunxiao Sun, Jianbin Li, Biyun Wang, Min Yan, Feng Jin, Haibo Wang, Jin Zhang, Peifen Fu, Tianyu Zeng, Jian Wang, Wei Li, Yongfei Li, Mengzhu Yang, Jun Li, Hao Wu, Ziyi Fu, Yongmei Yin, Zefei Jiang
Published 2020-03-01
Article -
16
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China by Shaohua Zhang, Jianbin Li, Ruonan Xu, Qianjun Chen, Gang Sun, Ying Lin, Yali Cao, Yiding Chen, Cuizhi Geng, Yuee Teng, Jianyun Nie, Xinzheng Li, Guiying Xu, Xinlan Liu, Feng Jin, Zhimin Fan, Ting Luo, Hong Liu, Fu-sheng Wang, Zefei Jiang
Published 2023-12-01
Article -
17
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial by Jiong Wu, Zefei Jiang, Zhenzhen Liu, Benlong Yang, Hongjian Yang, Jinhai Tang, Kun Wang, Yunjiang Liu, Haibo Wang, Peifen Fu, Shuqun Zhang, Qiang Liu, Shusen Wang, Jian Huang, Chuan Wang, Shu Wang, Yongsheng Wang, Linlin Zhen, Xiaoyu Zhu, Fei Wu, Xiang Lin, Jianjun Zou
Published 2022-12-01
Article -
18
Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial by Yang Yang, Yingjian He, Zhaoqing Fan, Xue Chen, Yiqiang Liu, Chao Zhang, Hongchuan Jiang, Xin Wang, Xiang Wang, Fei Xie, Shu Wang, Bin Luo, Hua Kang, Tao Wang, Zefei Jiang, Peng Yuan, Binhe Xu, Ling Xu, Yinhua Liu, Jinfeng Li, Yuntao Xie, Tianfeng Wang, Tao Ouyang
Published 2023-07-01
Article -
19
Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial by Yang Yang, Yingjian He, Zhaoqing Fan, Xue Chen, Yiqiang Liu, Chao Zhang, Hongchuan Jiang, Xin Wang, Xiang Wang, Fei Xie, Shu Wang, Bin Luo, Hua Kang, Tao Wang, Zefei Jiang, Peng Yuan, Binhe Xu, Ling Xu, Yinhua Liu, Jinfeng Li, Yuntao Xie, Tianfeng Wang, Tao Ouyang
Published 2023-06-01
Article -
20
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China by Yun Wu, Yiqun Han, Pei Yu, Quchang Ouyang, Min Yan, Xiaojia Wang, Xichun Hu, Zefei Jiang, Tao Huang, Zhongsheng Tong, Shusen Wang, Yongmei Yin, Hui Li, Runxiang Yang, Huawei Yang, Yuee Teng, Tao Sun, Li Cai, Hongyuan Li, Xi Chen, Jianjun He, Xinlan Liu, Shune Yang, Youlin Qiao, Jinhu Fan, Jiayu Wang, Binghe Xu
Published 2021-02-01
Article